GENE ONLINE|News &
Opinion
Blog

M&A
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Kriya Scoops Up Redpin to Break into Neurology Gene Therapies
2022-11-16
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
Myovant Turns Down $2.4 Billion Buyout Bid From Sumitomo
2022-10-03
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
CVS Beats Amazon in Signify Bidding War with $8 Billion Acquisition Offer
2022-09-06
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
1 2 3 4 5 13
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top